Tilray Brands (TLRY) Short-term Investments (2018 - 2026)
Tilray Brands' (TLRY) quarterly Short-term Investments came in at $5.3 million in Q2 2026, down 84.76% YoY from $34.7 million in Q2 2025, and down 65.46% on a QoQ basis from $15.3 million in Q1 2026.
Tilray Brands (TLRY) Short-term Investments (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 8 years of Short-term Investments data on file, last reported at $5.3 million in Q2 2026.
- Quarterly Short-term Investments fell 84.76% year-over-year to $5.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.3 million (down 84.76% YoY) and the FY2026 annual result came in at $5.3 million, down 84.76% from the prior year.
- Short-term Investments eased to $5.3 million in Q2 2026, from $15.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $287.3 million in Q3 2023 to a low of $5.3 million in Q2 2026.
- A 5-year average of $114.0 million and a median of $74.9 million in 2024 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2024 — Short-term Investments plunged 86.7% — and 2025, when it gained 7.81%.
- Tracing TLRY's Short-term Investments over 5 years: stood at $243.3 million in 2022, then sank by 52.15% to $116.4 million in 2023, then sank by 46.27% to $62.6 million in 2024, then fell by 28.3% to $44.8 million in 2025, then sank by 88.21% to $5.3 million in 2026.
- The last three Short-term Investments figures came in at $5.3 million (Q2 2026), $15.3 million (Q1 2026), and $44.8 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 5.29 Mn |
| Feb 28, 2026 | 15.31 Mn |
| Nov 30, 2025 | 44.85 Mn |
| May 31, 2025 | 34.70 Mn |
| Nov 30, 2024 | 62.55 Mn |
| Aug 31, 2024 | 74.87 Mn |
| May 31, 2024 | 32.18 Mn |
| Feb 29, 2024 | 79.61 Mn |
| Nov 30, 2023 | 116.42 Mn |
| Aug 31, 2023 | 287.33 Mn |
| May 31, 2023 | 241.90 Mn |
| Feb 28, 2023 | 243.29 Mn |
| Nov 30, 2022 | 243.29 Mn |
| Mar 31, 2020 | 20.08 Mn |
| Dec 31, 2019 | 25.49 Mn |
| Sep 30, 2019 | 45.26 Mn |
| Mar 31, 2019 | 31.23 Mn |
| Dec 31, 2018 | 30.34 Mn |
| Sep 30, 2018 | 14.71 Mn |